[Utilisation of fatty acids by rat kidney (cortex slices and glomeruli) in daunomycin induced nephrotic syndrome (author's transl)].
D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism; D003065:Coenzyme A / Q000378:metabolism; D003630:Daunorubicin / Q000008:administration & dosage*; D005227:Fatty Acids / Q000378:metabolism*; D005260:Female; D007657:Ketone Bodies / Q000378:metabolism; D007668:Kidney / Q000187:drug effects*; D007672:Kidney Cortex / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D007678:Kidney Glomerulus / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D009404:Nephrotic Syndrome / Q000201:enzymology / Q000378:metabolism*; D010101:Oxygen Consumption; D051381:Rats
D005227:Fatty Acids; D007657:Ketone Bodies; D002245:Carbon Dioxide; D003065:Coenzyme A; D003630:Daunorubicin
Fettsäureutilisation in der Rattenniere (Rindenschnitte und Glomerula) beim nephrotischen Syndrom nach Daunomycinapplikation